Brickell Biotech Announces Pricing of $15.0 Million Underwritten Public Offering
October 24, 2020 at 09:34 AM EDT
Brickell’s pipeline consists of potential novel therapeutics for hyperhidrosis and other prevalent dermatological conditions.
